(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas

por Richardson, Leland G., Choi, Bryan D., Curry, William T.
Publicado 2019

The Role of Antibody-Based Therapies in Neuro-Oncology

por Ramapriyan, Rishab, Sun, Jing, Curry, Annabel, Richardson, Leland G., Ramesh, Tarun, Gaffey, Matthew A., Gedeon, Patrick C., Gerstner, Elizabeth R., Curry, William T., Choi, Bryan D.
Publicado 2023

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

por Li, Ming, Li, Guoping, Kiyokawa, Juri, Tirmizi, Zain, Richardson, Leland G., Ning, Jianfang, Das, Saumya, Martuza, Robert L., Stemmer-Rachamimov, Anat, Rabkin, Samuel D., Wakimoto, Hiroaki
Publicado 2020

IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice

por Richardson, Leland G., Nieman, Linda T., Stemmer-Rachamimov, Anat O., Zheng, Xijin S., Stafford, Khalifa, Nagashima, Hiroaki, Miller, Julie J., Kiyokawa, Juri, Ting, David T., Wakimoto, Hiroaki, Cahill, Daniel P., Choi, Bryan D., Curry, William T.
Publicado 2020

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

por Schmidts, Andrea, Srivastava, Ambike A, Ramapriyan, Rishab, Bailey, Stefanie R, Bouffard, Amanda A, Cahill, Daniel P, Carter, Bob S, Curry, William T, Dunn, Gavin P, Frigault, Matthew J, Gerstner, Elizabeth R, Ghannam, Jack Y, Kann, Michael C, Larson, Rebecca C, Leick, Mark B, Nahed, Brian V, Richardson, Leland G, Scarfò, Irene, Sun, Jing, Wakimoto, Hiroaki, Maus, Marcela V, Choi, Bryan D
Publicado 2022